Edwards Tells Justices To Skip CoreValve Patent Case
Edwards Lifesciences AG urged the U.S. Supreme Court last week to reject CoreValve Inc.'s appeal of a $73.9 million heart valve patent verdict, saying the Medtronic Inc. unit's claim that the...To view the full article, register now.
Already a subscriber? Click here to view full article